logo

For the Inventor, By the Inventor

Hopkinton, MA, United States of America

Gargey Yagnik

This inventor holds 8 USPTO granted patents and 5 published patent applications. Top assignee: Ambergen, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gargey Yagnik. Retrieved from https://idiyas.com/inventor/gargey-yagnik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal7 out of 45 
 
Ambergen, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2023-2026

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12618852 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2026-05-05),
2. 12235277 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2025-02-25),
3. 12181482 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2024-12-31),
4. 12181481 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2024-12-31),
5. 12078639 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2024-09-03),
6. 11940447 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2024-03-26),
7. 11906527 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2024-02-20),
8. 11789027 - Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes (2023-10-17),

Title: Gargey Yagnik: Innovator in Mass Spectrometric Imaging

Introduction

Gargey Yagnik is a prominent inventor based in Hopkinton, MA (US). He has made significant contributions to the field of immunohistochemistry and in situ hybridization through his innovative patents. With a total of seven patents to his name, Yagnik is recognized for his advancements in biomolecular detection and mapping.

Latest Patents

One of Gargey Yagnik's latest patents focuses on photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes. This invention is particularly relevant for targeted detection and mapping of biomolecules, such as proteins and miRNAs, in tissues or cells. It serves both research and clinical purposes, aiding pathologists in biomarker analyses of tumors. The invention utilizes mass spectrometric imaging (MSI) to detect and map biomolecules effectively. It also encompasses the use of photocleavable mass-tag reagents attached to various probes, including antibodies and nucleic acids, to achieve multiplex immunohistochemistry and in situ hybridization. Furthermore, the invention includes multi-omic MSI procedures, combining MSI of photocleavable mass-tag probes with other modes of MSI.

Career Highlights

Gargey Yagnik is currently employed at Ambergen, Inc., where he continues to develop innovative solutions in the field of mass spectrometry. His work has significantly impacted the way biomolecules are analyzed and understood in clinical settings.

Collaborations

Throughout his career, Yagnik has collaborated with notable colleagues, including Mark J Lim and Kenneth J Rothschild. These collaborations have further enhanced the research and development of his innovative technologies.

Conclusion

Gargey Yagnik is a distinguished inventor whose work in mass spectrometric imaging has advanced the field of biomolecular analysis. His contributions are vital for both research and clinical applications, showcasing the importance of innovation in science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…